A carregar...
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points
OBJECTIVE: To evaluate the onset of efficacy of TEV-48125, a monoclonal antibody against calcitonin gene-related peptide, recently shown to be effective for the preventive treatment of chronic migraine (CM) and high-frequency episodic migraine. METHODS: A randomized placebo-controlled study tested o...
Na minha lista:
| Publicado no: | Neurology |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4932236/ https://ncbi.nlm.nih.gov/pubmed/27281531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000002801 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|